Answers are grounded in this paper and cite their sources.
Herein we demonstrate organocatalyst-mediated protein aldol ligation (OPAL) modification of the bacteriocidin colicin Ia to afford mannose-presenting neoglycoproteins with potential utility for non-genetic glyco-engineering of E. coli cell surfaces.
No takes yet. Share an insight, caveat, or question.
Hatton et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: